Joy Davis

626 total citations
7 papers, 484 citations indexed

About

Joy Davis is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Joy Davis has authored 7 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 3 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Joy Davis's work include Alzheimer's disease research and treatments (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Pluripotent Stem Cells Research (2 papers). Joy Davis is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Pluripotent Stem Cells Research (2 papers). Joy Davis collaborates with scholars based in United States and Germany. Joy Davis's co-authors include Mathew Blurton‐Jones, Frank M. LaFerla, Wayne W. Poon, Rahasson R. Ager, Francisca Benavente, Eliezer Masliah, Kristine Freude, Brian Spencer, Nicholas A. Castello and Frank Müller and has published in prestigious journals such as Journal of Biological Chemistry, Vaccine and Hippocampus.

In The Last Decade

Joy Davis

7 papers receiving 480 citations

Peers

Joy Davis

MB

PHYSI

DN

CMN

NEURO

Abinaya Chandrasekaran Denmark

Francisca Benavente United States

Joanna A. Korecka Netherlands

Sarah M. Brooker United States

Stina Leskelä Finland

Enrique Armijo United States

Larysa Voytenko Ukraine

Diogo Trigo Portugal

Chew L. Lau Australia

Federico La Regina Italy

Abinaya Chandrasekaran Denmark

Joy Davis

331 ×1.4

MB

146 ×0.6

PHYSI

127 ×0.7

DN

176 ×1.1

CMN

100 ×1.1

NEURO

Citations per year, relative to Joy Davis Joy Davis (= 1×) peers Abinaya Chandrasekaran

Countries citing papers authored by Joy Davis

Since Specialization

Citations

This map shows the geographic impact of Joy Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Davis more than expected).

Fields of papers citing papers by Joy Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Davis. The network helps show where Joy Davis may publish in the future.

Co-authorship network of co-authors of Joy Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Joy Davis. A scholar is included among the top collaborators of Joy Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy Davis. Joy Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Davtyan, Hayk, Karen Zagorski, Joy Davis, et al.. (2017). MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice. Vaccine. 35(16). 2015–2024. 19 indexed citations

2.

Agadjanyan, Michael G., Karen Zagorski, Irina Petrushina, et al.. (2017). Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency. Molecular Neurodegeneration. 12(1). 33–33. 36 indexed citations

3.

Marsh, Samuel E., Stephen T. Yeung, M.D. Martínez del Valle Torres, et al.. (2017). HuCNS-SC Human NSCs Fail to Differentiate, Form Ectopic Clusters, and Provide No Cognitive Benefits in a Transgenic Model of Alzheimer's Disease. Stem Cell Reports. 8(2). 235–248. 46 indexed citations

4.

Goldberg, Natalie R.S., et al.. (2015). Neural Stem Cells Rescue Cognitive and Motor Dysfunction in a Transgenic Model of Dementia with Lewy Bodies through a BDNF-Dependent Mechanism. Stem Cell Reports. 5(5). 791–804. 55 indexed citations

5.

Blurton‐Jones, Mathew, Brian Spencer, Sara Michael, et al.. (2014). Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models. Stem Cell Research & Therapy. 5(2). 46–46. 96 indexed citations

6.

Ager, Rahasson R., Joy Davis, Francisca Benavente, et al.. (2014). Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss. Hippocampus. 25(7). 813–826. 170 indexed citations

7.

Freude, Kristine, et al.. (2011). Soluble Amyloid Precursor Protein Induces Rapid Neural Differentiation of Human Embryonic Stem Cells. Journal of Biological Chemistry. 286(27). 24264–24274. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact